Telemedicine in the Era of a Pandemic: Usefulness of a Novel Three-Lead ECG

Author:

Babic Milos D.1ORCID,Veljkovic Stefan1,Lakcevic Jovana1,Babic Rade12ORCID,Ostojic Miodrag12,Petrovic Masa12ORCID,Boljevic Darko1ORCID,Tomic Stanko3,Bojic Milovan1,Nikolic Aleksandra12

Affiliation:

1. Dedinje Cardiovascular Institute, 11000 Belgrade, Serbia

2. Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia

3. Vinca Institute of Nuclear Sciences,11000 Belgrade, Serbia

Abstract

The 12-lead electrocardiogram (ECG) is a first-line diagnostic tool for patients with cardiac symptoms. As observed during the COVID-19 pandemic, the ECG is essential to the initial patient evaluation. The novel KardioPal three-lead-based ECG reconstructive technology provides a potential alternative to a standard ECG, reducing the response time and cost of treatment and improving patient comfort. Our study aimed to evaluate the diagnostic accuracy of a reconstructed 12-lead ECG obtained by the KardioPal technology, comparing it with the standard 12-lead ECG, and to assess the feasibility and time required to obtain a reconstructed ECG in a real-life scenario. A prospective, nonrandomized, single-center, adjudicator-blinded trial was conducted on 102 patients during the COVID-19 pandemic at the Dedinje Cardiovascular Institute in Belgrade. The KardioPal system demonstrated a high feasibility rate (99%), with high specificity (96.3%), sensitivity (95.8%), and diagnostic accuracy (96.1%) for obtaining clinically relevant matching of reconstructed 12-lead compared to the standard 12-lead ECG recording. This novel technology provided a significant reduction in ECG acquisition time and the need for personnel and space for obtaining ECG recordings, thereby reducing the risk of viral transmission and the burden on an already overwhelmed healthcare system such as the one experienced during the COVID-19 pandemic.

Publisher

MDPI AG

Subject

Clinical Biochemistry

Reference36 articles.

1. Virtually Perfect? Telemedicine for COVID-19;Hollander;N. Engl. J. Med.,2020

2. Bhatt, A., Freeman, A., and Mullen, B. (2020). Telehealth: Rapid Implementation for Your Cardiology Clinic. Am. Colege Cardiol., 24.

3. Telemedicine During the COVID-19 Pandemic: Experiences from Western China;Hong;J. Med. Internet Res.,2020

4. Cardiovascular manifestations and treatment considerations in COVID-19;Kang;Heart,2020

5. QTc interval prolongation in patients infected with SARS-CoV-2 and treated with antiviral drugs;Dolader;An. Pediatría (Engl. Ed.),2022

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3